Zdrowie i gospodarka · 27/02/2004
FDA Reopens Comment Period for Draft Guidance on Marketed Unapproved Drugs
The FDA is reopening the comment period for its draft guidance on marketed unapproved drugs until April 27, 2004, allowing industry to review and submit comments on the document.
Source: Federal Register — Food and Drug AdministrationOpen original release →